Late-liver-stage malaria vaccine delivers 89% protection and boosts cellular immunity

Genetically attenuated malaria parasites with extended liver-stage arrest (GA2) showed 89% protection in a clinical trial, surpassing earlier vaccine candidates and highlighting the potential of cellular immunity.

Long-Acting Schizophrenia Tx Shows Long-Term Safety With Limited Relapses

NASHVILLE, Tenn. — Every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) for schizophrenia was effective and safe up to 3 years, researchers reported

September 12, 2023

Nurses Still the Most Trusted Profession, Doctors Fall to Fifth

Nurses remained the most trusted profession in the U.S., while medical doctors dropped to the fifth spot, according to Gallup’s 2023 Honesty and Ethics poll.

January 25, 2024

AI algorithm may better support clinical care and research by identifying patients with adverse social determinants of health

A new study explores the use of large language models (LLMs) to obtain such vital data from EHRs to improve research outcomes and offer better

January 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.